Filter by: patients
Home > Community Treatment Reports and Side Effects > Isradipine Treatment Report
What is Isradipine?

Isradipine is a calcium channel blocker of the dihydropyridine class. It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack. More recent research suggests that isradipine may have potential uses for treating Parkinson's disease.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 16 3 Efficacy_major Efficacy_cant_tell
Other 8 4 Efficacy_moderate Efficacy_slight Efficacy_none
Elevated blood pressure 6 1 Efficacy_major
Hypertension 2 0
Raynaud's Disease 1 0
This Calcium Channel blocker (CCB) may offer some neuroprotection for PD 1 0

See all 25 patients currently taking Isradipine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 0
Mild
 0
None
 6

Commonly reported side effects, conditions, and hospitalizations associated with Isradipine

Swollen feet 1
Headaches 1
Dizziness with hypotension upon standing 1
Swelling in feet 1

Reported Dosages

  daily 2.5 mg daily 5 mg daily 10 mg daily 20 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 8 Number of Patients: 8 9 Number of Patients: 9 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Isradipine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 3   Expense: 38%
Course of treatment ended 2   Course of treatment ended: 25%
Not indicated 2   Not indicated: 25%
Doctor's advice 2   Doctor's advice: 25%
Did not seem to work 2   Did not seem to work: 25%
Side effects too severe 1   Side effects too severe: 13%
Other 1   Other: 13%

See all 8 patients who’ve stopped taking Isradipine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Isradipine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Isradipine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Isradipine

Always
 7 88%
Usually
 1 13%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Isradipine

Very
 1 13%
Somewhat
 0 0%
A little
 1 13%
Not at all
 6 75%

Cost

Paid out of pocket

Cost of Isradipine

$200+
 0 0%
$100-199
 0 0%
$50-99
 2 40%
$25-49
 1 20%
< $25
 2 40%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.